ADVANZ PHARMA Corp. Limited Sustainability Profile
ADVANZ PHARMA Corp. Limited, headquartered in Great Britain, is a prominent player in the pharmaceutical industry, specialising in the development and commercialisation of specialty and generic medicines. Founded in 2018, the company has rapidly established itself across key operational regions, including Europe and North America, focusing on therapeutic areas such as oncology, neurology, and infectious diseases. With a commitment to providing high-quality, accessible healthcare solutions, ADVANZ PHARMA offers a diverse portfolio of products that stand out for their efficacy and safety. The company has achieved significant milestones, including strategic partnerships and a growing market presence, positioning itself as a trusted provider in the pharmaceutical landscape. Through innovation and a patient-centric approach, ADVANZ PHARMA continues to enhance its reputation and impact within the healthcare sector.
DitchCarbon Score
How does ADVANZ PHARMA Corp. Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ADVANZ PHARMA Corp. Limited's score of 28 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
ADVANZ PHARMA Corp. Limited's reported carbon emissions
ADVANZ PHARMA Corp. Limited, headquartered in the United Kingdom, is committed to addressing climate change through various initiatives. While specific carbon emissions data is currently unavailable, the company has made significant commitments to reduce its environmental impact. ADVANZ PHARMA has established near-term targets as part of its commitment to the Science Based Targets initiative (SBTi), indicating a proactive approach to managing its carbon footprint. The company is classified as "Committed" to these targets, although specific reduction goals and timelines have not been disclosed. As a participant in the pharmaceuticals, biotechnology, and life sciences sector, ADVANZ PHARMA is aware of the industry's environmental responsibilities and is taking steps to align with global climate standards. The absence of emissions data suggests that the company may be in the early stages of its carbon accounting journey, but its commitment to SBTi reflects a dedication to future transparency and accountability in emissions reporting. Overall, ADVANZ PHARMA's climate commitments signal a forward-thinking approach to sustainability, positioning the company to contribute positively to the global effort against climate change.
How Carbon Intensive is ADVANZ PHARMA Corp. Limited's Industry?
How Carbon Intensive is ADVANZ PHARMA Corp. Limited's Location?
ADVANZ PHARMA Corp. Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ADVANZ PHARMA Corp. Limited has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.